Personalized vs. Fixed-Activity 177Lu-PSMA-617 Radiopharmaceutical Therapy (PRODIGY-2)

Clinical trial NCT06943495 · RECRUITING

Trial details

NCT number: NCT06943495
Sponsor: Jean-Mathieu Beauregard
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Start date: 2025-08-15
Primary completion: 2029-03-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.